These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12399205)

  • 1. The implication of a reduced-dose hepatitis B vaccination schedule in low risk newborns.
    Lee SS; Young BW; Wong KH; Lim WL
    Vaccine; 2002 Nov; 20(31-32):3752-4. PubMed ID: 12399205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
    Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the status of immune memory after completion of hepatitis B vaccination].
    Li YP; Li RC; Fang KX; Li HM; Hu ZY; He P; Wu XY; Zhang R; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):319-21. PubMed ID: 17850693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
    Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
    Yan B; Lyu J; Liu J; Feng Y; Xu A; Chen S; Zhou L; Liang X; Cui F; Wang F; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1043-7. PubMed ID: 25619213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the anti-hepatitis B vaccination efficacy in high risk children.
    Nedelcu I; Crăciun D; Târdei G; Ruţă SM; Grancea C; Cernescu C
    Rom J Virol; 1998; 49(1-4):43-51. PubMed ID: 10892425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.
    Velu V; Nandakumar S; Shanmugam S; Jadhav SS; Kulkarni PS; Thyagarajan SP
    World J Gastroenterol; 2007 Jun; 13(22):3084-9. PubMed ID: 17589924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
    Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
    Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
    Krairittichai U; Sethakarun S
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.